(Q36371912)

13 August 2017

1 reference

title

The contribution of PET/CT to improved patient management (English)

1 reference

13 August 2017

1 reference

Ell PJ

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

British Journal of Radiology

13 August 2017

published in

1 reference

13 August 2017

volume

79

1 reference

13 August 2017

issue

937

1 reference

13 August 2017

page(s)

32-36

1 reference

PET/CT: a new imaging technology in nuclear medicine.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Clinical role of positron emission tomography in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Functional imaging of malignant paragangliomas and carcinoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

The role of PET imaging in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Clinical decisions associated with positron emission tomography in a prospective cohort of patients with suspected or known cancer at one United States center

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

FDG-PET in the clinical management of Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Positron emission tomography and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

FDG-PET for the pre-operative evaluation of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Potential impact of [ 18 F]3'-deoxy-3'-fluorothymidine versus [ 18 F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F18454286

21 January 2018

Identifiers

DOI

10.1259/BJR/18454286

1 reference

13 August 2017

1 reference